B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression

Abstract Mantle cell lymphoma (MCL) is an incurable B-cell malignancy characterized by a high clinical variability. Therefore, there is a critical need to define parameters that identify high-risk patients for aggressive disease and therapy resistance. B-cell receptor (BCR) signaling is crucial for...

Cijeli opis

Bibliografski detalji

Glavni autori:	Simona Gambino, Francesca Maria Quaglia, Marilisa Galasso, Chiara Cavallini, Roberto Chignola, Ornella Lovato, Luca Giacobazzi, Simone Caligola, Annalisa Adamo, Santosh Putta, Antonino Aparo, Isacco Ferrarini, Stefano Ugel, Rosalba Giugno, Massimo Donadelli, Ilaria Dando, Mauro Krampera, Carlo Visco, Maria Teresa Scupoli
Format:	Artigo
Jezik:	Inglês
Izdano:	Nature Portfolio 2024-03-01
Serija:	Scientific Reports
Online pristup:	https://doi.org/10.1038/s41598-024-55728-9
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!